Disease | breast cancer |
Phenotype | C0151313|sensory peripheral neuropathy |
Sentences | 1 |
PubMedID- 23204130 | Experimental design: a gwas of paclitaxel-induced cytotoxicity was conducted in 247 lcls from the hapmap project and compared with a gwas of sensory peripheral neuropathy in patients with breast cancer (n = 855) treated with paclitaxel in the cancer and leukemia group b (calgb) 40101 trial. |
Page: 1